Sponsor Check › Issuer
Corporation · organized in DELAWARE · formed Over five years ago · VALENCIA, CA · SEC CIK 1665933
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 19, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Coming soon.
What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.
No comparisons published yet.
Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:12 PM ET.
0 of 5 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Aug 1, 2016 D/A File 021-260643 | $0 | $0 | $0 (est.) | None listed |
| EDGAR ↗ | Aug 2, 2017 D File 021-291971 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Aug 18, 2020 D/A File 021-371665 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | May 15, 2023 D File 021-481715 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Oct 19, 2026 D File 021-601743 | $0 | $0 | $0 | None listed |
As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.
Each filing as reported by the issuer. Open a row for the full plain-English detail.
| Filing | Form D filed Oct 19, 2026 SEC file no. 021-601743 · accession 0001665933-26-000004 |
|---|---|
| Raise progress | $8,904,819 sold of $10,859,182 offered (82%) · $1,954,363 remaining |
| Filing timing | Date of first sale: Oct 5, 2026 · Form D filed: Oct 19, 2026 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 19 days (0.1 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 10 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anthony K. Arnold, CEO (Oct 19, 2026) |
| Market context | Minimum investment: $0. Typical range for similar offerings: $5,000–$50,000. Offering size: $10,859,182. Typical range: $500,000–$7,000,000. Investors: 10. Typical range: 2–14. "Similar" = Other offerings claiming 506(b) filed in the last 5 years (18,678 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index |
| Filing | Form D filed May 15, 2023 SEC file no. 021-481715 · accession 0001665933-23-000001 |
|---|---|
| Raise progress | $7,799,784 sold of $8,826,449 offered (88%) · $1,026,665 remaining |
| Filing timing | Date of first sale: May 2, 2023 · Form D filed: May 15, 2023 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,271 days (3.5 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 23 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anthony Arnold, President and CEO (May 15, 2023) |
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310. Offering size: $8,826,449. Typical range: $829,831–$9,999,998. Investors: 23. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Aug 18, 2020 · amends 0001665933-20-000002 ↗ SEC file no. 021-371665 · accession 0001665933-20-000003 |
|---|---|
| Raise progress | $4,124,330 sold of $4,124,330 offered (100%) · $0 remaining |
| Filing timing | Date of first sale: Jul 10, 2020 · Form D filed: Aug 18, 2020 (39 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,297 days (6.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 25 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anthony Arnold, President and CEO (Aug 18, 2020) |
| Changes vs prior filing | total sold: $3,420,958 → $4,124,330 total offering: $4,100,000 → $4,124,330 investors: 19 → 25 Compared with the D filed Jul 23, 2020 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $1. Typical range for similar offerings: $5,000–$50,000. Offering size: $4,124,330. Typical range: $500,000–$7,000,000. Investors: 25. Typical range: 2–14. "Similar" = Other offerings claiming 506(b) filed in the last 5 years (18,678 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Jul 23, 2020 SEC file no. 021-371665 · accession 0001665933-20-000002 |
|---|---|
| Raise progress | $3,420,958 sold of $4,100,000 offered (83%) · $679,042 remaining |
| Filing timing | Date of first sale: Jul 10, 2020 · Form D filed: Jul 23, 2020 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 2,297 days (6.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 19 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Anthony Arnold, President and CEO (Jul 23, 2020) |
| Market context | Minimum investment: $1. Typical range for similar offerings: $5,000–$50,000. Offering size: $4,100,000. Typical range: $500,000–$7,000,000. Investors: 19. Typical range: 2–14. "Similar" = Other offerings claiming 506(b) filed in the last 5 years (18,678 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Aug 2, 2017 SEC file no. 021-291971 · accession 0001665933-17-000001 |
|---|---|
| Raise progress | $3,726,119 sold of $4,024,348 offered (93%) · $298,229 remaining |
| Filing timing | Date of first sale: Jul 20, 2017 · Form D filed: Aug 2, 2017 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,383 days (9.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 11 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Thomas Bruggere, President (Aug 2, 2017) |
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310. Offering size: $4,024,348. Typical range: $829,831–$9,999,998. Investors: 11. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Aug 1, 2016 · amends 0001665933-16-000002 ↗ SEC file no. 021-260643 · accession 0001665933-16-000003 |
|---|---|
| Raise progress | $1,953,795 sold of $1,953,795 offered (100%) · $0 remaining |
| Filing timing | Date of first sale: Mar 29, 2016 · Form D filed: Aug 1, 2016 (125 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,861 days (10.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 13 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) |
| Signed by | Thomas Bruggere, President (Aug 1, 2016) |
| Changes vs prior filing | total sold: $1,499,999 → $1,953,795 total offering: $1,612,255 → $1,953,795 investors: 10 → 13 Compared with the D filed Apr 5, 2016 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310. Offering size: $1,953,795. Typical range: $829,831–$9,999,998. Investors: 13. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Apr 5, 2016 SEC file no. 021-260643 · accession 0001665933-16-000002 |
|---|---|
| Raise progress | $1,499,999 sold of $1,612,255 offered (93%) · $112,256 remaining |
| Filing timing | Date of first sale: Mar 29, 2016 · Form D filed: Apr 5, 2016 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,861 days (10.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 10 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) |
| Signed by | Thomas Bruggere, President (Apr 4, 2016) |
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$54,310. Offering size: $1,612,255. Typical range: $829,831–$9,999,998. Investors: 10. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
All Form D filings for this CIK on SEC EDGAR ↗. History: 1 new offering in the last 12 months · most recent filing Oct 19, 2026 · industry as reported over time: Other Health Care → Other.
| Name | Relationship | Address state | On filings | Also listed on |
|---|---|---|---|---|
| Aman Mahajan | Director | CA | Apr 5, 2016 → Oct 19, 2026 | — |
| Anthony K. Arnold | Executive Officer, Director | CA | Oct 19, 2026 | — |
| Derrick Sung | Director | CA | May 15, 2023 → Oct 19, 2026 | — |
| Erick Hawkins | Director | CA | May 15, 2023 → Oct 19, 2026 | — |
| Kanav Saraf | Executive Officer | CA | Oct 19, 2026 | — |
| Rusty Page | Executive Officer | CA | Oct 19, 2026 | — |
| Victroia K. Grace | Director | CA | Oct 19, 2026 | — |
| William Kaiser | Executive Officer | CA | Apr 5, 2016 → Oct 19, 2026 | — |
| Aman J. Mahajan | Director | CA | May 15, 2023 | — |
| Anthony Arnold | Executive Officer, Director | CA | Jul 23, 2020 → May 15, 2023 | 1 other issuer |
| Victoria Grace | Director | CA | May 15, 2023 | 3 other issuers |
| William J. Kaiser | Executive Officer | CA | May 15, 2023 | — |
| Aman G. Mahajan | Executive Officer, Director | CA | Jul 23, 2020 → Aug 18, 2020 | — |
| Bradford G. Jones | Director | CA | Jul 23, 2020 → Aug 18, 2020 | — |
| Derrick G. Sung | Director | CA | Jul 23, 2020 → Aug 18, 2020 | 1 other issuer |
| Victoria K. Grace | Director | CA | Apr 5, 2016 → Aug 18, 2020 | 3 other issuers |
| William J Kaiser | Executive Officer | CA | Jul 23, 2020 → Aug 18, 2020 | — |
| G. Bradford Jones | Director | CA | Apr 5, 2016 → Aug 2, 2017 | 1 other issuer |
| Thomas Bruggere | Executive Officer, Director | CA | Apr 5, 2016 → Aug 2, 2017 | — |
Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index.
Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.
Export this report as PDF (all source links + data timestamp; members)
No corrections have been requested for this page.
The complete public-record profile for Sensydia Corp, plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.